PPIPT00893
Target Protein Information
| Protein_Name | HBc antigen |
|---|---|
| Protein_Sequence | MPSDFFPSIRDLLDTASALYREALESPEHCTPHHTALRQAILCWGELMNLATWVGSNLEDPASRELVVGYVNVNMGLKLRQLLWFHLSCLTFGRETVLEYLVSFGVWIRTPPAYRPQNAPILSTLPETTVIRRRGRSPRRRTPSPRRRRSQSPRRRRSQSREPQC |
| Organism_Source | Hepatitis B virus |
| Functional_Classification | HBc antigen |
| Cellular_Localization | Cytoplasm |
| Gene_Names | None |
| UniProt_ID | Q2AC05 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | ADGSLIGRMKGAAG |
|---|---|
| Peptide_Sequence | ADGSLIGRMKGAAG |
| Peptide_Length | 14 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)O |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Free |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 1303.50 |
|---|---|
| Aliphatic_Index | 77.14286 |
| Aromaticity | 0.00000 |
| Average_Rotatable_Bonds | 3.21429 |
| Charge_at_pH_7 | 0.99813 |
| Isoelectric_point | 9.69502 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 20 |
| Number_of_Hydrogen_Bond_Donors | 21 |
| Topological_Polar_Surface_Area | 587.07000 |
| X_logP_energy | -8.00943 |
Interaction Information
| Affinity | IC50=4.5 uM |
|---|---|
| Affinity_Assay | Competitive binding assay |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHEDVA PEPTIDE LIGANDS |
| Release_Year | 2012 |
| Patent_ID | US20120321659A1 |